Sign up to our newsletter Subscribe
Establishing the Economic Value of Carbon-Minimal Inhalers

Sign up to our newsletter Subscribe
Aidan Hollis is Professor of Economics at the University of Calgary, and President of Incentives for Global Health. Hollis studied at Cambridge University and the University of Toronto, where he obtained a PhD in economics. He has worked in the private sector and in government. His research focuses on innovation and competition in pharmaceutical markets, and he has published over eighty peer–reviewed articles and two books in a range of fields of economics. He has provided expert reports and testimony in a variety of pharmaceutical–related cases in Federal, Appeals and Supreme Court cases in Canada, and has advised companies and governments.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!